<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03644901</url>
  </required_header>
  <id_info>
    <org_study_id>UDDS-Perio-03-2018</org_study_id>
    <nct_id>NCT03644901</nct_id>
  </id_info>
  <brief_title>Assessment of Response to the Conventional Periodontal Treatment Based on the Blood Group Phenotypes.</brief_title>
  <official_title>Investigating the Role of ABO Blood Group in the Response to the Nonsurgical Periodontal Treatment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to find out if one blood group phenotype is more responsive than the
      others to the nonsurgical periodontal treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To the best of our knowledge, this is the first (research) randomized clinical trial that
      assesses how patient respond to the nonsurgical periodontal treatment based on their blood
      group phenotype.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Actual">March 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in relative attachment level.</measure>
    <time_frame>measures will be taken at baseline and after two months from treatment.</time_frame>
    <description>the relative attachment level measures the length form the base of the periodontal pocket to a stent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in periodontal probing depth.</measure>
    <time_frame>measures will be taken at baseline and after two months from treatment.</time_frame>
    <description>the distance between the gingival margin to the base of the periodontal pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in gingival index</measure>
    <time_frame>index will be taken at baseline and after two months from treatment.</time_frame>
    <description>it is used to designate the level of the gingival inflammation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plaque Index</measure>
    <time_frame>index will be taken at baseline and after two months from treatment.</time_frame>
    <description>it is used to designate the level of plaque accumulation.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Patients whose blood type is A</arm_group_label>
    <description>Applying nonsurgical periodontal treatment (scaling and root planning).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients whose blood type is B</arm_group_label>
    <description>Applying nonsurgical periodontal treatment (scaling and root planning).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients whose blood type is AB</arm_group_label>
    <description>Applying nonsurgical periodontal treatment (scaling and root planning).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients whose blood type is O</arm_group_label>
    <description>Applying nonsurgical periodontal treatment (scaling and root planning).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nonsurgical periodontal treatment</intervention_name>
    <description>patients will undergo nonsurgical periodontal treatment to reduce the relative attachment level and improve the probing depth. An initial session will be conducted to remove supra gingival plaque and calculus. another appointment is set to perform full moth scalling and root planing.</description>
    <arm_group_label>Patients whose blood type is A</arm_group_label>
    <arm_group_label>Patients whose blood type is AB</arm_group_label>
    <arm_group_label>Patients whose blood type is B</arm_group_label>
    <arm_group_label>Patients whose blood type is O</arm_group_label>
    <other_name>Conventional periodontal treatment</other_name>
    <other_name>scalling and root planing</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from chronic periodontitis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  systematically healthy.

          -  have at least 20 teeth excluding the third molars.

          -  had not received any periodontal treatment or antibiotic therapy for dental or medical
             reason 6 month prior to the study.

          -  diagnosed with generalized chronic periodontitis (&gt;30% of the sites have probing depth
             â‰¥4), and a minimum of six teeth with probing depth of 5-6 mm.

        Exclusion Criteria:

          -  smokers and alcoholics.

          -  pregnancy.

          -  history of a systematic disease such as diabetes, leukemia, epilepsy.

          -  participants who are unable to perform routine oral hygiene.

          -  use of orthodontic appliances.

          -  participants who are unable to perform routine oral hygiene.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Ammar Kouky, DDS MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>PhD Student in Periododontics, University of Damascus Dental School, Damascus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad Monzer Alsabbagh, DDS MSc PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Associate Professor of Periodontics, University of Damascus Dental School, Damascus, Syria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Periodontics</name>
      <address>
        <city>Damascus</city>
        <zip>DM20AM18</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <reference>
    <citation>Pai GP, Dayakar MM, Shaila M, Dayakar A. Correlation between &quot;ABO&quot; blood group phenotypes and periodontal disease: Prevalence in south Kanara district, Karnataka state, India. J Indian Soc Periodontol. 2012 Oct;16(4):519-23. doi: 10.4103/0972-124X.106892.</citation>
    <PMID>23493096</PMID>
  </reference>
  <reference>
    <citation>Demir T, Tezel A, Orbak R, Eltas A, Kara C, Kavrut F. The Effect of ABO Blood Types on Periodontal Status. Eur J Dent. 2007 Jul;1(3):139-43.</citation>
    <PMID>19212557</PMID>
  </reference>
  <reference>
    <citation>Gautam A, Mittal N, Singh TB, Srivastava R, Verma PK. Correlation of ABO Blood Group Phenotype and Rhesus Factor with Periodontal Disease: An Observational Study. Contemp Clin Dent. 2017 Apr-Jun;8(2):253-258. doi: 10.4103/ccd.ccd_307_17.</citation>
    <PMID>28839412</PMID>
  </reference>
  <reference>
    <citation>Wang W, Liu L, Wang Z, Wei M, He Q, Ling T, Cao Z, Zhang Y, Wang Q, Shi M. Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer. BMC Surg. 2015 Sep 29;15:106. doi: 10.1186/s12893-015-0094-1.</citation>
    <PMID>26420728</PMID>
  </reference>
  <reference>
    <citation>Yu Q, Wang L, Zhang S, Feng T, Li L, Chen B, Chen M. The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment. Blood Transfus. 2016 Sep;14(5):460-4. doi: 10.2450/2016.0199-15. Epub 2016 Feb 24.</citation>
    <PMID>27136434</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2018</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

